Related Experiment Video
Updated: Jun 24, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
[Clinical trials registers. Introduction to the topic and backgrounds].
G Antes1, G Dreier, H Hasselblatt
1Deutsches Cochrane Zentrum, Institut für Medizinische Biometrie und Medizinische Informatik, Universitätsklinikum Freiburg, Stefan-Meier-Strasse 26, 79104, Freiburg. antes@cochrane.de
Summary
Publishing clinical trial results is a moral imperative. A German clinical trials register aims to combat publication bias and ensure accurate treatment assessments by addressing under-reporting of negative results.
Area of Science:
- Clinical Research
- Medical Ethics
- Health Policy
Context:
- Ethical obligations necessitate the publication of all clinical trial outcomes.
- Under-reporting of null/negative results and over-reporting of positive findings distort treatment evaluations.
- Publicly accessible clinical trial registries are crucial for bridging information gaps.
Purpose:
- To describe the rationale for establishing a clinical trials register in Germany.
- To specifically address the issue of publication bias in clinical research.
Summary:
- Clinical studies must report all results to uphold ethical standards and ensure scientific integrity.
- Publication bias, including selective reporting of positive outcomes, can lead to inaccurate perceptions of treatment efficacy and safety.
- Implementing a national clinical trials register in Germany is proposed to mitigate these issues.
Impact:
- Enhances the reliability of evidence-based medicine by providing a complete picture of trial outcomes.
- Promotes transparency and accountability in clinical research.
- Aims to improve patient safety and optimize therapeutic decision-making by preventing biased treatment assessments.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...